THERAPY BY ANTIMALARIA (AMINOOUINOLINE) DRUGS AND OF OCULAR SAFETY

THERAPY BY ANTIMALARIA (AMINOOUINOLINE) DRUGS AND OF OCULAR SAFETY

Saved in:

Bibliographic Details
Main Authors:	Yu. V. Mouraviev, E P Turgieva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2002-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/413
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computational approaches in drug chemistry leveraging python powered QSPR study of antimalaria compounds by using artificial neural networks
by: Wakeel Ahmed, et al.
Published: (2025-06-01)

ANALISIS HUBUNGAN KUANTITATIF STRUKTUR DAN AKTIVITAS ANTIMALARIA SENYAWA TURUNAN QUINOXALIN
by: M. Noor, et al.
Published: (2016-11-01)

Prevalence of antimalaria drug resistance-conferring mutations associated with sulphadoxine-pyrimethamineine-resistant Plasmodium falciparum in East Africa: a systematic review and meta-analysis
by: Wagaw Abebe, et al.
Published: (2025-04-01)

Detrimental effects of irrational drug therapy on the ocular surface
by: Abha Gour, et al.
Published: (2022-01-01)

INHIBITORY ACTIVITY OF BIOACTIVE COMPOUNDS IN BLACK SEA CUCUMBER (HOLOTHURIA ATRA) AGAINST FALCIPAIN-2 PROTEIN IN PLASMODIUM FALCIPARUM AS ANTIMALARIA BASED ON IN SILICO STUDY
by: Alifiah Wahyu Nur Fadilah, et al.
Published: (2025-05-01)

Circumsporozoite Protein-Specific Kd-Restricted CD8+ T Cells Mediate Protective Antimalaria Immunity in Sporozoite-Immunized MHC-I-Kd Transgenic Mice
by: Jing Huang, et al.
Published: (2014-01-01)

Artistic life of North Ossetia in the context of socio-political and economic changes (1991-2001)
by: Z. A. Turgieva
Published: (2024-09-01)

Drug Safety Issues in Therapy COVID-19
by: D. G. Levitova, et al.
Published: (2020-05-01)

Ocular proton therapy: state-of-the-art
by: V. O. Karpunin, et al.
Published: (2023-10-01)

Psychotropic Drugs and Ocular Side Effects
by: İpek Sönmez, et al.
Published: (2014-03-01)

Ocular toxicity of Anti-Tubercular drugs
by: Ritika Aggarwal, et al.
Published: (2021-04-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

The clinical safety landscape for ocular AAV gene therapies: A systematic review and meta-analysis
by: Zishi Liu, et al.
Published: (2025-04-01)

Drugs Used in Ocular Local Anaesthesia: An Overview
by: Anam Ansari, et al.
Published: (2022-01-01)

Ocular Drug Delivery: Emerging Approaches and Advances
by: Shilpkala Gade, et al.
Published: (2025-05-01)

Ocular Drug Delivery Role of Contact Lenses
by: Anubhav Chauhan
Published: (2015-10-01)

Dendrimeric Systems and Their Applications in Ocular Drug Delivery
by: Burçin Yavuz, et al.
Published: (2013-01-01)

Advancements in hydrogel technology for ocular drug delivery
by: Doanh Truong, et al.
Published: (2024-12-01)

TREATMENT OF RHEUMATIC DISEASES INTERRELATION OF SELECTIVE NON-STEROIDAL ANTIINFLAMMATORY DRUG CELEBREX (CELECOXIB) AND INHIBITOR OF ENZYME WITH APF ENAP (ENALAPR1L) IN PATIENTS WITH RHEUMATIC DISEASES AND CONCOMITANT ARTERIAL HYPERTENSION
by: Yu. V. Mouraviev, et al.
Published: (2002-06-01)

Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab
by: Asim V. Farooq, et al.
Published: (2025-05-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Essential topical ocular diagnostic drugs for the family practitioner
by: D. Meyer
Published: (2004-06-01)

Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery
by: Sandip Karmakar, et al.
Published: (2025-01-01)

Topical Ocular Drug Delivery: The Impact of Permeation Enhancers
by: Gonçalo Santos, et al.
Published: (2025-03-01)

How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
by: Martha Kim, et al.
Published: (2024-12-01)

Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01)

The Choice of Dry Eye Therapy Depending on Ocular Surface Condition
by: S. V. Yanchenko, et al.
Published: (2021-07-01)

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
by: S. Yu. Degtyareva, et al.
Published: (2019-04-01)

Stem Cell Therapy for Treatment of Ocular Disorders
by: Padma Priya Sivan, et al.
Published: (2016-01-01)

Ocular toxicity of biological therapy in solid tumors
by: Ioana Claudia Popteanu, et al.
Published: (2022-01-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Adverse ocular effects of neuroleptic therapy: semiotics, pathogenesis and treatment
by: A. A. Panov, et al.
Published: (2022-01-01)

New nonsteroidal anti-inflammatory drug in the treatment of different ocular pathology
by: A. J. Slonimskij, et al.
Published: (2016-04-01)

Combined Therapy Using Mesenchymal Stem Cells and Metal Nanoparticles: Perspectives for Ocular Injuries and Diseases
by: Holan V, et al.
Published: (2025-06-01)

Effectiveness, safety and assessing the results of drug therapy in patients with epilepsy
by: article Editorial
Published: (2021-10-01)

Photobiomodulation in ocular therapy: current status and future perspectives
by: Hasan Chichan, et al.
Published: (2025-02-01)

Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases
by: Lin X, et al.
Published: (2025-07-01)

Vancomycin-Loaded Gel Ocular Drug Delivery System for Treatment of Endophthalmitis
by: Ebru Erdal
Published: (2024-06-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Ocular surface changes in allergic blepharoconjunctivitis and dry eye syndrome: diagnosis and therapy possibilities
by: S. N. Sakhnov, et al.
Published: (2024-03-01)